📰 Immune News
Page 35 - Immune News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immune. Real-time updates on events, politics, business and more.
April 20, 2023
The researchers from the Okinawa Institute of Science and Technology (OIST) in Japan report that increased
April 20, 2023
According to Okinawa Institute of Science and Technology researchers, gut bacteria that break down a sugar called fucose may be suppressing our immune response to the Covid-19 mRNA vaccine (OIST).
April 20, 2023
Aditxt, Inc. , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive... | April 20, 2023
April 19, 2023
Older people and those with weakened immune systems may get a second dose of Omicron-targeting COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention said on Wednesday. ... | April 19, 2023
April 18, 2023
Singapore, April 16: A team of researchers has unearthed how cancer evades the immune system and spreads throughout the body and is investigating ways to get rid of this potentially harmful trait.
April 18, 2023
First blood-only liquid biopsy test for monitoring molecular response to immune checkpoint inhibitors now covered for US Medicare patients with metastatic or inoperable solid tumors ... | April 18, 2023
April 18, 2023
New Phase I data confirm promising immunogenicity and efficacy profile of TG4050, an individualized neoantigen cancer vaccine developed by Transgene in collaboration with NEC Corporation In the head
April 18, 2023
The US Centers for Disease Control and Prevention defines TBE as a disease caused by a virus. The virus spreads to people via bite from an infected tick, eating or drinking unpasteurised dairy products (milk and cheese) from infected goats, sheep, or cows.The
April 18, 2023
WASHINGTON — U.S. regulators on Tuesday cleared another booster dose of the Pfizer or Moderna COVID-19 vaccines for older Americans and people with weak immune systems. The Food and Drug... | April 18, 2023
April 17, 2023
Invir.IO® based oncolytic virus TG6050, is armed with IL-12 and an anti-CTLA4 antibody. A Phase I trial (Delivir) recently started enrolling patients with advanced non-small cell lung cancer (NSCLC)